This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brousset, P. Articles by Delsol, G. Search for Related Content PubMed PubMed Citation Articles by Brousset, P. Articles by Delsol, G. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Thyroid Cancer

Telomerase Activity in Human Thyroid Carcinomas Originating from the Follicular Cells¹

Laboratoire d’Anatomie Pathologique and CNRS (P.B., N.C., R.C.Z., G.D.), UPR8291, Centre Hospitalier Universitaire de Purpan, 31059 Toulouse Cédex; Service d’Endocrinologie (F.L.), Hôpital Haut Lévèque, Bordeaux; Service d’Endocrinologie (F.B.-B.), Centre Hospitalier Universitaire de Rangueil, Toulouse; and Laboratoire d’Anatomie Pathologique (H.T., J.-P.M.), CHU de Bordeaux, France

Address all correspondence and requests for reprints to: Pierre Brousset, M.D., Ph.D., Laboratoire d’Anatomie Pathologique, Centre Hospitalier Universitaire de Purpan, Place du Dr Baylac, 31059 Toulouse Cédex, France.

Telomerase activity is known to be absent from most normal and well-differentiated tissues, although being detectable in the vast majority of malignant tumors. An increasing number of reports demonstrate that telomerase may be activated in benign tumors, such as adenomas. We have investigated a series of normal and neoplastic thyroid tissues for the presence of telomerase activity. As expected, all normal thyroid tissues (n = 20) had no display of telomerase activity. Amongst cancers, the incidence of telomerase activity varied with the histological subtypes. Telomerase activity was present in only 3/15 cases (20%) of papillary carcinomas. Telomerase activity was more frequently detected in follicular (4/6) and in undifferentiated (2/3) carcinomas. Unexpectedly, one case (1/12) of adenoma contained high levels of telomerase activity. Taken together, these results indicate that telomerase may play some role in the pathogenesis of thyroid tumors, in particular in follicular and undifferentiated carcinomas that are known to have the most aggressive behavior.

This article has been cited by other articles:

				M. Capezzone, S. Cantara, S. Marchisotta, S. Filetti, M. M. De Santi, B. Rossi, G. Ronga, C. Durante, and F. Pacini Short Telomeres, Telomerase Reverse Transcriptase Gene Amplification, and Increased Telomerase Activity in the Blood of Familial Papillary Thyroid Cancer Patients J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3950 - 3957. [Abstract] [Full Text] [PDF]

				C. B. Umbricht, G. T. Conrad, D. P. Clark, W. H. Westra, D. C. Smith, M. Zahurak, M. Saji, R. C. Smallridge, S. Goodman, and M. A. Zeiger Human Telomerase Reverse Transcriptase Gene Expression and the Surgical Management of Suspicious Thyroid Tumors Clin. Cancer Res., September 1, 2004; 10(17): 5762 - 5768. [Abstract] [Full Text] [PDF]

				H. Kanauchi, N. Wada, D. G. Ginzinger, M. Yu, M. G. Wong, O. H. Clark, and Q.-Y. Duh Diagnostic and Prognostic Value of Fas and Telomeric-Repeat Binding Factor-1 Genes in Adrenal Tumors J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3690 - 3693. [Abstract] [Full Text] [PDF]

				L. Teng, M. C. Specht, C. B. Barden, and T. J. Fahey III Antisense hTERT Inhibits Thyroid Cancer Cell Growth J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1362 - 1366. [Abstract] [Full Text] [PDF]

				M. Saji, S. Xydas, W. H. Westra, C.-K. Liang, D. P. Clark, R. Udelsman, C. B. Umbricht, S. Sukumar, and M. A. Zeiger Human Telomerase Reverse Transcriptase (hTERT) Gene Expression in Thyroid Neoplasms Clin. Cancer Res., June 1, 1999; 5(6): 1483 - 1489. [Abstract] [Full Text] [PDF]

				X. De Deken, C. Vilain, J. Van Sande, J. E. Dumont, and F. Miot Decrease of Telomere Length in Thyroid Adenomas without Telomerase Activity J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4368 - 4372. [Abstract] [Full Text]